Hypera SA 2025 IR
The report details Hypera Pharma Group's financial, operational, and ESG performance for the fiscal year 2025. Key highlights include achieving a net revenue of R$ 7,699.2 million, representing a 3.4% growth compared to 2024, and a record cash flow from operations of R$ 2,574.4 million. On the environmental front, the company reduced its Scope 1 emissions intensity by 9.97% and electricity consumption by 1.7% compared to the previous year. Additionally, the group successfully completed its working capital optimization process ahead of schedule and updated its corporate governance structure with the inclusion of Votorantim S.A. in its controlling block.
Company: Hypera SA
Sector: Manufacturing
Country: Brazil
Year: 2025
Type: IR
Pages: 113
Back to company
Hypera SA
Annual Sustainability Report
The report details Hypera Pharma Group's financial, operational, and ESG performance for the fiscal year 2025. Key highlights include achieving a net revenue of R$ 7,699.2 million, representing a 3.4% growth compared to 2024, and a record cash flow from operations of R$ 2,574.4 million. On the environmental front, the company reduced its Scope 1 emissions intensity by 9.97% and electricity consumption by 1.7% compared to the previous year. Additionally, the group successfully completed its working capital optimization process ahead of schedule and updated its corporate governance structure with the inclusion of Votorantim S.A. in its controlling block.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees